Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The guideline on minimally invasive heart valve interventions will be evaluated by the Institute for Quality Assurance and Transparency in Health Care (IQTIG) in Germany

On the 15th of February, 2018 the Federal Joint Committee (G-BA) has commissioned the Institute for Quality Assurance and Transparency in Health Care (IQTIG) to evaluate the guideline on minimally invasive heart valve interventions (MHI-RL), which came into force in July, 2015.

In this guideline the G-BA has set minimum quality standards for the implementation of minimally invasive heart valve interventions. If the hospital wishes to continue offering transcatheter aortic valve implantation (TAVI) or mitral clip valve procedures, it should meet the following requirements:

  • TAVI interventions may only be carried out in hospitals with a department of internal medicine and cardiology;
  • TAVI interventions can be carried out by jointly operated facilities of two legally independent hospitals if all the structural and process quality requirements of the guideline are met (e.g., the department of cardiology and cardiac surgery should be located close to each other);
  • To offer a clip procedure on the mitral valve, the hospital must have at least one of two cardiology and cardiac surgery departments in one building.

The evaluation report has to be submitted by December 31, 2019.

See full details in German here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.